Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases, Nature Chemical Biology, 2008 Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development, Lab Chip, 2010, 10, 13. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics, Nature Chemical Biology, 2007 Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context, Mol. Biosyst., 2010, 6, 1293. MEMS microwell and microcolumn arrays: novel methods for high-throughput cell-based assays, Lab Chip, 2011, 11, 3619. Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors, Mol. Biosyst., 2012, 8, 2645. Superiority of a novel EGFR targeted covalent inhibitor over its reversible counterpart in overcoming drug resistance, Med. Chem. Commun., 2012, 3, 780. Toward personalized cancer nanomedicine – past, present, and future, Integr. Biol., 2013, 5, 48. Manipulating the lateral diffusion of surface-anchored EGF demonstrates that receptor clustering modulates phosphorylation levels, Integr. Biol., 2013, 5, 659. Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: influence of the position 4 substituent, Med. Chem. Commun., 2013, 4, 1202.